CPL-423

N/A

Report date: 2025/06/11 11:06:17
NME

Base Information

Drug NameCPL-423
Drug Alias NameMER/FLT3 inhibitor (Celon Pharma)MER/TAM family kinase inhibitor (Celon Pharma)CPL-2CPL-423
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitorsAnticancer protein kinase inhibitorsAXL receptor tyrosine kinase inhibitors +[5] 
TargetsTYRO3 protein tyrosine kinaseTyrosine-protein kinase receptor FLT3AXL receptor tyrosine kinase +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelon Pharma SP
China Registration ClassN/A

Develop Information

Active CompaniesCelon Pharma SP
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A